FDA Approvals - FDA Approves VELCADE(R) (Bortezomib) for Injection for Aggressive Form of
FDA Approves VELCADE(R) (Bortezomib) for Injection for Aggressive Form of Non-Hodgkin's Lymphoma (PR Newswire via Yahoo! Finance)
Millennium Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted full approval of VELCADE for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy.
FDA Approves First Generic Ondansetron Injection (DrugDiscoveryOnline)
The U. S. Food and Drug Administration (FDA) recently approved first generic versions of Zofran (Ondansetron) Injection and Zofran (Ondansetron) Injection Premixed